These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
610 related articles for article (PubMed ID: 30096321)
21. Racial disparities in treatment and survival of male breast cancer. Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572 [TBL] [Abstract][Full Text] [Related]
22. Explaining black-white differences in receipt of recommended colon cancer treatment. Baldwin LM; Dobie SA; Billingsley K; Cai Y; Wright GE; Dominitz JA; Barlow W; Warren JL; Taplin SH J Natl Cancer Inst; 2005 Aug; 97(16):1211-20. PubMed ID: 16106026 [TBL] [Abstract][Full Text] [Related]
23. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies. Rauh-Hain JA; Melamed A; Schaps D; Bregar AJ; Spencer R; Schorge JO; Rice LW; Del Carmen MG Gynecol Oncol; 2018 Apr; 149(1):4-11. PubMed ID: 29605048 [TBL] [Abstract][Full Text] [Related]
24. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample. Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890 [TBL] [Abstract][Full Text] [Related]
25. Socioeconomic inequality and omission of adjuvant radiation therapy in high-risk, early-stage endometrial cancer. Luo LY; Aviki EM; Lee A; Kollmeier MA; Abu-Rustum NR; Tsai CJ; Alektiar KM Gynecol Oncol; 2021 May; 161(2):463-469. PubMed ID: 33597092 [TBL] [Abstract][Full Text] [Related]
27. Adjuvant treatment and outcomes for patients with stage IIIA grade 1 endometrioid endometrial cancer. Montes de Oca MK; Albright BB; Secord AA; Havrilesky LJ; Moss HA Int J Gynecol Cancer; 2021 Dec; 31(12):1549-1556. PubMed ID: 34725205 [TBL] [Abstract][Full Text] [Related]
28. Racial disparities in survival in malignant germ cell tumors of the ovary. Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer. Lester-Coll NH; Young MR; Park HS; Ratner ES; Litkouhi B; Damast S Int J Gynecol Cancer; 2017 Nov; 27(9):1904-1911. PubMed ID: 28763364 [TBL] [Abstract][Full Text] [Related]
30. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW; J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132 [TBL] [Abstract][Full Text] [Related]
31. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer. Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497 [TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy for advanced endometrial cancer. Galaal K; Al Moundhri M; Bryant A; Lopes AD; Lawrie TA Cochrane Database Syst Rev; 2014 May; 2014(5):CD010681. PubMed ID: 24832785 [TBL] [Abstract][Full Text] [Related]
33. Racial disparities in treatment of high-grade endometrial cancer in the Medicare population. Rauh-Hain JA; Buskwofie A; Clemmer J; Boruta DM; Schorge JO; Del Carmen MG Obstet Gynecol; 2015 Apr; 125(4):843-851. PubMed ID: 25751197 [TBL] [Abstract][Full Text] [Related]
34. Socioeconomic disparities in breast cancer treatment among older women. White A; Richardson LC; Krontiras H; Pisu M J Womens Health (Larchmt); 2014 Apr; 23(4):335-41. PubMed ID: 24350590 [TBL] [Abstract][Full Text] [Related]
35. The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women. Cote ML; Ruterbusch JJ; Olson SH; Lu K; Ali-Fehmi R Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1407-15. PubMed ID: 26290568 [TBL] [Abstract][Full Text] [Related]
36. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study. van Weelden WJ; Reijnen C; Eggink FA; Boll D; Ottevanger PB; van den Berg HA; van der Aa MA; Pijnenborg JMA Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416 [TBL] [Abstract][Full Text] [Related]
37. The impact of race, comorbid conditions and obesity on survival endpoints in women with high grade endometrial carcinoma. Fucinari J; Elshaikh MA; Ruterbusch JJ; Khalil R; Dyson G; Shultz D; Ali-Fehmi R; Cote ML Gynecol Oncol; 2021 Jul; 162(1):134-141. PubMed ID: 33985795 [TBL] [Abstract][Full Text] [Related]
38. The National Cancer Data Base report on endometrial carcinoma in African-American women. Hicks ML; Phillips JL; Parham G; Andrews N; Jones WB; Shingleton HM; Menck HR Cancer; 1998 Dec; 83(12):2629-37. PubMed ID: 9874471 [TBL] [Abstract][Full Text] [Related]
39. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer. Sail K; Franzini L; Lairson D; Du X Ethn Health; 2012; 17(3):309-23. PubMed ID: 22066691 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study. Kuku S; Williams M; McCormack M Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]